Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05132686 · ClinicalTrials.gov registry record · NA
The Healthy Diet and Lifestyle Study II
A NA study of Intra-Abdominal Fat, sponsored by University of Hawaii.
- Recruiting
- Registry status
- NA
- Development phase
- 260
- Enrollment target
- 1
- Study location
NCT05132686 is a NA study of Intra-Abdominal Fat that is actively recruiting participants, run by University of Hawaii. The registered enrollment target is 260 participants. The trial reports 1 study location across 1 state.
The verdict
NCT05132686, a NA study of Intra-Abdominal Fat, is actively recruiting participants, sponsored by University of Hawaii.
- RECRUITING
- Registry status
- NA
- Development phase
- 260 participants
- Enrollment target
- 1
- Study location
Study Summary
Intermittent energy restriction (IER) may have important advantages over daily energy restriction (DER) in producing sustained weight loss and reducing cancer risk. IER is already being promoted with limited evidence, thus, additional evidence is urgently needed from rigorously conducted clinical trials. IER has been proposed to invoke a greater metabolic shift to fat metabolism than DER and preferentially reduce central obesity. The Investigators adapted the IER and the Mediterranean diet (MED) approach which have been recommended as a healthy weight-loss diet in the management of non-alcoholic fatty liver disease, for an ethnically diverse population. The effectiveness was compared to an active comparator (DASH diet) in reducing overall and visceral adiposity in a randomized trial among 60 middle-aged adults with visceral obesity. This 12-week pilot demonstrated the feasibility and safety of IER and the culturally-adapted MED \[NCT03639350\]. The six-month randomized trial will demonstrate the superiority of IER over DER in reducing fat and total fat mass, and in improving cancer-related biomarkers and gut microbiome functions. This longer trial, to confirm safety and superiority of IER over DER in reducing VAT and liver fat will expand our understanding of adherence to IER and its effect on the gut microbiome as a possible mediator of systemic inflammation. The Investigators will conduct a 24-week randomized trial of IER+MED vs. MED/DER among 260 middle-aged adults of East-Asian, Native Hawaiian and other Pacific Islanders or White ethnicity with high VAT. The primary research question is whether a diet plan combining IER and the MED dietary pattern will be superior to MED/DER in reducing abdominal MRI-measured visceral and liver fat and dual-energy X-ray absorptiometry (DXA) measured total adiposity. The Healthy Diet and Lifestyle Study II (HDLS2) will recruit 312 men and women from the general population with VAT at or above the population-median (men: ≥90 cm2;
Conditions Studied
Interventions
- BEHAVIORAL IER+MED
- BEHAVIORAL MED/DER
Study Locations (1)
Hawaii
- University of Hawaii Cancer Center - Honolulu
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 260 participants |
| Start Date | 2022-01-20 |
| Est. Completion | 2026-09-30 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05132686
The ClinicalTrials.gov registry entry for NCT05132686 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 260 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Hawaii, which has 77 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Intra-Abdominal Fat appearing as the primary indexed condition, and to 2 interventions - of which IER+MED is the first listed.
NCT05132686 reports 1 study location spanning 1 distinct geographic area - top geographies include Hawaii.
Frequently Asked Questions
What is clinical trial NCT05132686 about?
NCT05132686 is a clinical study titled "The Healthy Diet and Lifestyle Study II". Intermittent energy restriction (IER) may have important advantages over daily energy restriction (DER) in producing sustained weight loss and reducing cancer risk. IER is already being promoted with limited evidence, thus, additional evidence is urgently needed from rigorously conducted clinical tr...
What is the current status of trial NCT05132686?
This trial is currently recruiting. It is a NA study. The enrollment target is 260 participants. The study started on 2022-01-20. Estimated completion is 2026-09-30.
What conditions does trial NCT05132686 study?
This clinical trial studies the following conditions: Intra-Abdominal Fat.
What interventions are being tested in trial NCT05132686?
The interventions under investigation include: IER+MED (BEHAVIORAL), MED/DER (BEHAVIORAL).
Who is sponsoring clinical trial NCT05132686?
This trial is sponsored by University of Hawaii, which has 77 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05132686 being conducted?
This trial has 1 study location across Hawaii. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.